Ftse Mib
36.200,64
-0,18%
DAX
20.990,31
0,44%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
104.832,83
1,67%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cingulate Inc (CINGW) Cingulate Inc (CINGW) Notizie

Cingulate Inc

CINGW
0,0527
-0,021 (-28,49%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/1/202502:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202502:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202513:35EDGAR2Form 8-K - Current report
07/1/202513:30GLOBEFinal Study Completed for Cingulate’s Lead Asset CTx-1301
23/12/202413:35EDGAR2Form 8-K - Current report
23/12/202413:30GLOBECingulate Completes Financing Transaction for Net Proceeds..
15/11/202401:21EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202413:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:45EDGAR2Form 8-K - Current report
07/11/202413:30GLOBECingulate Reports Third Quarter 2024 Financial..
15/10/202414:05EDGAR2Form 8-K - Current report
15/10/202414:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/10/202421:15GLOBECingulate’s Shane Schaffer Joins Cast of Nationally..
08/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
07/10/202423:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/10/202415:02EDGAR2Form S-1/A - General form for registration of securities..
07/10/202414:00EDGAR2Form 8-K - Current report
04/10/202422:32EDGAR2Form 8-K - Current report
03/10/202412:09EDGAR2Form S-1/A - General form for registration of securities..
02/10/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202412:24EDGAR2Form S-1 - General form for registration of securities under..
12/9/202414:30EDGAR2Form 8-K - Current report
12/9/202414:30GLOBECingulate Initiates Final Study for Lead ADHD Asset CTx-1301
10/9/202412:02EDGAR2Form 8-K - Current report
27/8/202422:30GLOBECingulate to Participate in Benzinga All Live Access Event
23/8/202422:45GLOBECingulate Announces Adjournment of Special Meeting
15/8/202413:45GLOBECingulate Issued European Patent for Lead Asset CTx-1301 for..
13/8/202413:45GLOBECingulate Reports Second Quarter 2024 Financial Results and..
28/6/202415:15GLOBECingulate Announces Exercise of Warrants for $1.86 Million..
25/6/202422:30GLOBECingulate and ADHD Expert Dr. Ann Childress, MD to..
25/6/202415:20GLOBECingulate Achieves Key Manufacturing Milestone in the..
18/6/202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
18/6/202414:00EDGAR2Form 8-K - Current report
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202423:00EDGAR2Form 8-K - Current report
08/6/202400:00EDGAR2Form SC 13D/A - General statement of acquisition of..
28/5/202423:54EDGAR2Form SC 13D/A - General statement of acquisition of..
28/5/202415:20EDGAR2Form 8-K - Current report
23/5/202423:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/5/202415:00GLOBEFDA Clears Cingulate to File for Marketing Approval of..
17/5/202423:01EDGAR2Form S-1 - General form for registration of securities under..
13/5/202414:00EDGAR2Form 8-K - Current report
08/5/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:10EDGAR2Form 8-K - Current report
Apertura: 0,0689 Min: 0,0648 Max: 0,08
Chiusura: 0,0737

La tua Cronologia

NASDAQ
CINGW
Cingulate
BIT
UC8AMX
Unicredit Bank
BIT
S29006
Societe Generale Effekten
BIT
P1FL51
BNP Paribas Issuance
BIT
P1TM96
BNP Paribas Issuance
BIT
EUCH
ETFS Long CHF Short EUR
BIT
MNL
Monnalisa
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network